DNA Amplification

DNA Amplification Market Outlook

The global DNA amplification market is projected to reach a value of approximately USD 10 billion by 2035, growing at a robust compound annual growth rate (CAGR) of around 9% during the forecast period from 2025 to 2035. This impressive growth can be attributed to the increasing demand for rapid and precise diagnostic techniques in various applications, including clinical diagnostics, research, and forensics. Additionally, advancements in technology, such as the development of innovative amplification techniques and devices, have significantly enhanced the sensitivity and specificity of DNA amplification processes. The rising prevalence of genetic disorders and infectious diseases has further accelerated the adoption of DNA amplification methods, driving the market forward. Moreover, government initiatives promoting genetic research and personalized medicine are also fueling the growth of this sector, positioning it for sustained expansion in the coming years.

Growth Factor of the Market

Several key factors contribute to the growth of the DNA amplification market. Firstly, the increasing prevalence of genetic disorders, such as cystic fibrosis and sickle cell anemia, has heightened the demand for reliable diagnostic tools that can facilitate early detection and intervention. Secondly, the rise of personalized medicine, which tailors treatment strategies based on an individual's genetic makeup, has created a substantial market for DNA amplification technologies. Furthermore, the expanding applications of amplification techniques in areas such as drug development, agricultural biotechnology, and environmental monitoring have broadened the market's scope. Additionally, the ongoing advancements in technology and innovation in amplification methods have made these tools more accessible and user-friendly. Lastly, the global rise in research activities and funding dedicated to genomics and molecular biology is anticipated to further stimulate market growth.

Key Highlights of the Market

• The global DNA amplification market is expected to reach USD 10 billion by 2035, with a CAGR of approximately 9%.
• Increasing adoption of personalized medicine is driving the demand for DNA amplification techniques.
• Growth of genomic research and advancements in technology are key factors supporting market expansion.
• Clinical diagnostics is the leading application segment for DNA amplification technologies.
• North America is expected to dominate the market, followed closely by Europe and Asia Pacific.

By Product Type

Polymerase Chain Reaction (PCR):

Polymerase Chain Reaction (PCR) is one of the most widely used DNA amplification techniques, primarily due to its efficiency and versatility. This method enables the amplification of specific DNA sequences through repeated cycles of heating and cooling, which facilitates the denaturation, annealing, and extension of DNA strands. PCR is extensively utilized in various applications, including clinical diagnostics, genetic research, and forensic analysis. Its ability to amplify minute quantities of DNA makes it invaluable for detecting pathogens in infectious diseases and for genetic mutations in hereditary conditions. Moreover, advancements in PCR technology, such as real-time PCR and digital PCR, have enhanced its sensitivity and accuracy, making it a preferred choice among researchers and clinicians alike. The ongoing development of PCR-based techniques continues to propel the demand for this product type in the market.

Loop-mediated Isothermal Amplification (LAMP):

Loop-mediated Isothermal Amplification (LAMP) is an innovative DNA amplification technique characterized by its simplicity and rapidity. Unlike traditional PCR, which requires thermal cycling, LAMP operates at a constant temperature, utilizing a set of specially designed primers and a DNA polymerase enzyme. This method enables the amplification of DNA in less than an hour, making it ideal for point-of-care diagnostics and field applications. LAMP has gained traction in areas such as infectious disease detection, including viral infections like COVID-19, due to its rapid turnaround time and high specificity. The growing focus on decentralized diagnostic solutions, especially in resource-limited settings, has further bolstered the adoption of LAMP technology. As researchers continue to explore its applications, LAMP is poised to play a significant role in the evolution of DNA amplification methodologies.

Nucleic Acid Sequence Based Amplification (NASBA):

Nucleic Acid Sequence Based Amplification (NASBA) is a unique amplification technique that targets RNA sequences, offering a crucial advantage in the detection and analysis of RNA viruses and gene expression studies. This method employs a series of enzymatic reactions to amplify RNA targets, ultimately converting them into DNA for further analysis. NASBA is particularly valuable in the field of infectious disease diagnostics, as it allows for the rapid and sensitive detection of viral RNA, which is essential for timely clinical decision-making. The increasing incidence of viral infections, coupled with the rising need for accurate and efficient diagnostic methods, has propelled the demand for NASBA in both research and clinical settings. Its applications extend beyond diagnostics to include areas such as therapeutic monitoring and vaccine development, showcasing the versatility of this amplification technique.

Strand Displacement Amplification (SDA):

Strand Displacement Amplification (SDA) is an innovative DNA amplification method that operates at a constant temperature, making it simpler and faster compared to traditional PCR approaches. SDA utilizes a combination of DNA polymerase and specific primers to amplify target DNA sequences while displacing existing strands. This technique is particularly advantageous in point-of-care settings, where rapid results are crucial. Its applications in clinical diagnostics, especially for detecting bacterial infections, have gained prominence due to its high sensitivity and specificity. Furthermore, SDA can be integrated with various detection systems, enhancing its adaptability for different testing environments. As the demand for rapid diagnostic solutions continues to rise, SDA is expected to witness significant growth in the DNA amplification market.

Multiple Displacement Amplification (MDA):

Multiple Displacement Amplification (MDA) is a unique amplification technique that allows for the extensive amplification of single or low-copy number DNA templates. This method is particularly useful in applications where the starting material is limited, such as in ancient DNA or forensic samples. MDA employs a DNA polymerase enzyme that displaces existing strands during amplification, resulting in significant yield while maintaining the fidelity of the original sequence. The technique's ability to produce large amounts of DNA quickly has made it a valuable tool in genomic research and clinical applications, including whole-genome amplification. As advancements in MDA technology continue to emerge, its potential for enhancing various research and diagnostic applications is expected to expand, contributing to the overall growth of the DNA amplification market.

By Application

Clinical Diagnostics:

Clinical diagnostics represents one of the largest and most critical application segments in the DNA amplification market. The ability to accurately detect and diagnose genetic disorders, infectious diseases, and cancer is paramount in modern healthcare, and DNA amplification techniques serve as essential tools in achieving these objectives. With the rising incidence of chronic diseases, such as diabetes and cancer, there is an increasing reliance on DNA amplification technologies to provide timely and accurate diagnostic results. Techniques like PCR and LAMP are particularly valuable for identifying pathogens and monitoring disease progression, offering healthcare professionals critical information for treatment decisions. Moreover, the shift toward personalized medicine, which tailors medical interventions based on individual genetic profiles, further emphasizes the significance of DNA amplification in clinical settings. As healthcare continues to evolve, the demand for advanced and reliable diagnostic solutions will likely propel the growth of this application segment.

Research:

Research is another prominent application area for DNA amplification technologies, with extensive use in fields such as genomics, molecular biology, and biotechnology. Researchers leverage amplification techniques to study gene expression, analyze genetic variations, and conduct various experiments that require precise DNA manipulation. The ability to amplify specific DNA sequences quickly and accurately is crucial for a wide range of applications, including cloning, sequencing, and genotyping. The growing focus on genetic research, particularly in areas such as cancer genomics and personalized medicine, has fueled the demand for advanced DNA amplification methods. Furthermore, as funding for genomic research continues to increase, the adoption of DNA amplification technologies in academic and clinical laboratories is set to rise, contributing to the overall market growth.

Forensics:

The forensics application segment has witnessed significant growth in the DNA amplification market, driven by the increasing use of genetic information in criminal investigations and legal proceedings. DNA amplification techniques, particularly PCR, are pivotal in analyzing evidence collected from crime scenes, such as blood, hair, and tissue samples. The ability to obtain a complete DNA profile from trace amounts of biological evidence has revolutionized forensic science, enabling law enforcement agencies to solve cases more effectively. As public awareness of forensic science evolves and the demand for accurate identification methods increases, the reliance on DNA amplification in forensics is expected to expand. Additionally, the integration of DNA databases and advancements in forensic technologies will further enhance the role of DNA amplification in solving crimes and securing convictions.

By Distribution Channel

Hospitals & Diagnostic Centers:

Hospitals and diagnostic centers are key distribution channels for DNA amplification technologies, primarily due to the growing demand for efficient diagnostic solutions in healthcare settings. These facilities often utilize a variety of amplification methods, including PCR and LAMP, to facilitate the rapid detection of infectious diseases and genetic disorders. The integration of molecular diagnostics into routine clinical practice has heightened the need for reliable and accurate amplification techniques, prompting hospitals and diagnostic centers to adopt advanced technologies. Moreover, as healthcare systems focus on improving patient outcomes through timely diagnosis and treatment, the role of DNA amplification in clinical laboratories has become increasingly essential. The continuous advancements in molecular testing and the ongoing investment in diagnostic capabilities are expected to drive the growth of this distribution channel.

Research Laboratories:

Research laboratories represent another significant distribution channel for DNA amplification technologies, catering to the needs of academic institutions, biotechnology companies, and pharmaceutical firms. These laboratories rely heavily on amplification methods to conduct experiments, analyze genetic material, and develop new therapies. The growing emphasis on genetic research and the exploration of novel applications in areas such as gene therapy and synthetic biology have heightened the demand for advanced amplification technologies. As funding for research continues to increase and collaborative projects expand, research laboratories are likely to invest in state-of-the-art DNA amplification tools to enhance their capabilities. The diverse applications of DNA amplification in research settings, coupled with ongoing technological advancements, are expected to propel the growth of this distribution channel.

By Technology Type

PCR:

Polymerase Chain Reaction (PCR) remains the gold standard in DNA amplification technologies, widely adopted in both clinical and research settings due to its unparalleled sensitivity and specificity. The PCR process involves repeated cycles of denaturation, annealing, and extension, resulting in the exponential amplification of target DNA sequences. The versatility of PCR allows for its application in a broad spectrum of fields, from infectious disease diagnostics to genetic research and forensic analysis. Moreover, advancements in PCR technology, such as quantitative PCR (qPCR) and reverse transcription PCR (RT-PCR), have enabled researchers to quantify gene expression and detect RNA targets effectively. The increasing reliance on PCR-based methods in various applications highlights its significance in the DNA amplification market, ensuring continued growth and innovation in this technology.

LAMP:

Loop-mediated Isothermal Amplification (LAMP) is gaining traction as a valuable alternative to traditional PCR methods, characterized by its rapid amplification process and simplicity. Operating at a constant temperature, LAMP eliminates the need for sophisticated thermal cycling equipment, making it particularly suitable for point-of-care diagnostics and field applications. The ability to amplify DNA in under an hour has made LAMP especially popular for detecting infectious diseases, including emerging viral infections. Its high specificity and tolerance to inhibitors further enhance its utility in various settings. As researchers continue to explore the versatility of LAMP in food safety, environmental monitoring, and agricultural applications, the technology's adoption is expected to grow, contributing to the overall expansion of the DNA amplification market.

NASBA:

Nucleic Acid Sequence Based Amplification (NASBA) offers a unique approach to DNA amplification, specifically targeting RNA sequences. This technique is particularly advantageous in areas such as viral diagnostics, where the detection of RNA viruses is crucial for timely clinical interventions. NASBA utilizes a combination of enzymes and primers to amplify RNA, converting it into DNA for further analysis. Its high sensitivity and ability to detect low copy numbers of RNA make it invaluable in clinical diagnostics and research applications. The increasing focus on RNA-based research and the need for accurate viral detection are expected to propel the demand for NASBA technology in the coming years. As advancements in NASBA continue to emerge, its role in the DNA amplification market will likely expand, further solidifying its importance.

SDA:

Strand Displacement Amplification (SDA) is an innovative technology that simplifies the DNA amplification process while ensuring high sensitivity and specificity. Operating at a constant temperature, SDA employs a unique combination of DNA polymerase and specific primers to amplify target sequences while efficiently displacing existing strands. This technique has gained popularity in clinical diagnostics, particularly for the rapid detection of bacterial infections. Its ability to produce results quickly and accurately makes it a suitable choice for point-of-care testing. Furthermore, the adaptability of SDA for integration with various detection systems enhances its appeal in diverse testing environments. As the demand for rapid and reliable diagnostic solutions grows, SDA is likely to play an increasingly significant role in the DNA amplification market.

MDA:

Multiple Displacement Amplification (MDA) is a specialized technique that enables the amplification of low-copy number DNA templates, making it particularly valuable in applications where the starting material is limited. MDA employs a unique polymerase enzyme that allows for efficient DNA amplification while maintaining the fidelity of the original sequence. This technique is widely used in genomic research, especially in whole-genome amplification for low-input samples such as ancient DNA or forensic evidence. The ability to generate significant quantities of DNA quickly has made MDA a preferred choice in various applications, from disease research to genetic studies. As advancements in MDA technology continue to unfold, its potential for enhancing diverse research applications is expected to expand, contributing to the overall growth of the DNA amplification market.

By Region

The DNA amplification market exhibits significant regional diversity, with North America poised to dominate the landscape, accounting for an estimated 40% of the total market share by 2035. This region's leadership can be attributed to the presence of advanced healthcare infrastructure, a robust research ecosystem, and high levels of investment in biotechnology and genomics. Furthermore, the increasing adoption of molecular diagnostics and the rising prevalence of genetic disorders in North America have further accelerated the demand for DNA amplification technologies. The CAGR in this region is projected to be around 9.5%, driven by continuous advancements in diagnostic methodologies and growing public awareness regarding genetic testing.

In Europe, the DNA amplification market is expected to hold a substantial share, contributing approximately 30% to the overall market by 2035. The region is characterized by a strong focus on research and development, supported by government initiatives and funding aimed at promoting genetic research and personalized medicine. The ongoing advancements in molecular biology techniques, coupled with the rising demand for high-quality diagnostic solutions, are anticipated to drive the growth of the DNA amplification market in Europe. Meanwhile, Asia Pacific is also set to witness significant growth, with a CAGR of around 8.5%, as countries like China and India invest in healthcare infrastructure and research capabilities, further enhancing the adoption of DNA amplification technologies.

Opportunities

The DNA amplification market presents numerous opportunities driven by advancements in technology and increasing applications across various sectors. One of the most significant opportunities lies in the growing demand for point-of-care testing solutions, particularly in developing regions where access to advanced healthcare facilities may be limited. The ability to deliver rapid and accurate diagnostic results in remote or resource-constrained environments positions DNA amplification technologies as vital tools in tackling public health challenges. Additionally, the rising focus on personalized medicine, which relies heavily on genetic testing and profiling, creates a growing market for DNA amplification techniques. As more healthcare providers seek to implement tailored treatment strategies, the demand for reliable amplification methods is expected to soar, paving the way for market expansion.

Furthermore, the ongoing advancements in automation and integration of DNA amplification technologies with digital platforms present additional avenues for growth. The development of automated systems for high-throughput amplification and analysis can significantly enhance laboratory efficiency and productivity, meeting the increasing demand for rapid and scalable testing solutions. Additionally, the rise of collaborations between research institutions, biotechnology companies, and healthcare providers is expected to foster innovation in DNA amplification technologies. These partnerships can lead to the development of novel applications and next-generation amplification techniques, further enriching the market landscape. Overall, the DNA amplification market is poised for substantial growth, leveraging emerging opportunities to enhance diagnostic capabilities and research advancements.

Threats

Despite the promising growth prospects in the DNA amplification market, several threats could potentially hinder its expansion. One of the primary concerns is the increasing competition among various amplification technologies, which may lead to market saturation and pricing pressures. As new and innovative methods emerge, traditional techniques such as PCR may face challenges in maintaining their market share, compelling manufacturers to invest in research and development to stay competitive. Additionally, the rapid pace of technological advancements may outdate existing amplification methods, requiring continuous adaptation and innovation from industry players to retain relevance.

Another significant threat lies in regulatory challenges and compliance requirements associated with molecular diagnostics and genetic testing. Stringent regulations governing the approval and commercialization of DNA amplification products can create barriers for new entrants and slow down the introduction of innovative technologies. Furthermore, ethical concerns surrounding genetic testing and privacy issues may lead to public apprehension, potentially limiting the market's growth. In light of these factors, stakeholders in the DNA amplification market must navigate these challenges strategically to ensure sustainable growth and maintain consumer trust.

Competitor Outlook

• Thermo Fisher Scientific Inc.
• QIAGEN N.V.
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• Roche Diagnostics
• Illumina, Inc.
• NEB (New England Biolabs) Inc.
• Takara Bio Inc.
• GE Healthcare
• Promega Corporation
• Merck KGaA
• PerkinElmer, Inc.
• LGC Limited
• DiaSorin S.p.A.
• Hologic, Inc.

The competitive landscape of the DNA amplification market is characterized by the presence of several established players and emerging companies striving to capture market share through innovation and strategic collaborations. Companies such as Thermo Fisher Scientific, QIAGEN, and Roche Diagnostics dominate the market, leveraging their extensive product portfolios and established distribution networks to deliver cutting-edge DNA amplification solutions. These industry leaders invest heavily in research and development, continuously enhancing their offerings to meet the evolving demands of the healthcare and research sectors. Furthermore, partnerships with academic institutions and biotechnology firms enable these companies to drive innovation and expand their technological capabilities, positioning them favorably in the competitive landscape.

Emerging companies, including startups specializing in novel amplification technologies, are also making their mark in the DNA amplification market. These firms often focus on niche applications or specific technologies, providing unique solutions that challenge established players. For instance, companies developing loop-mediated isothermal amplification (LAMP) technologies are gaining traction due to their rapid turnaround times and suitability for point-of-care diagnostics. As the market continues to evolve, the interplay between established players and emerging innovators will shape the competitive dynamics and drive advancements in DNA amplification technologies.

In summary, the DNA amplification market is characterized by a vibrant competitive landscape, with numerous players vying for market share through technological advancements, strategic partnerships, and comprehensive product offerings. As the demand for accurate and efficient diagnostic solutions continues to grow, industry participants must remain agile, leverage emerging opportunities, and navigate potential challenges to sustain their competitive edge. Major players, including Thermo Fisher Scientific and QIAGEN, are expected to continue leading the market, while innovative startups will play a crucial role in shaping the future of DNA amplification technologies. As the landscape evolves, the ongoing collaboration between research, industry, and clinical applications will drive further growth and innovation in the DNA amplification market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Merck KGaA
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 LGC Limited
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 QIAGEN N.V.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 GE Healthcare
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Hologic, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Illumina, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 DiaSorin S.p.A.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Takara Bio Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 PerkinElmer, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Roche Diagnostics
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Promega Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Agilent Technologies Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Bio-Rad Laboratories Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Thermo Fisher Scientific Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 NEB (New England Biolabs) Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 DNA Amplification Market, By Application
    • 6.1.1 Clinical Diagnostics
    • 6.1.2 Research
    • 6.1.3 Forensics
    • 6.1.4 Others
  • 6.2 DNA Amplification Market, By Product Type
    • 6.2.1 Polymerase Chain Reaction (PCR)
    • 6.2.2 Loop-mediated Isothermal Amplification (LAMP)
    • 6.2.3 Nucleic Acid Sequence Based Amplification (NASBA)
    • 6.2.4 Strand Displacement Amplification (SDA)
    • 6.2.5 Multiple Displacement Amplification (MDA)
  • 6.3 DNA Amplification Market, By Distribution Channel
    • 6.3.1 Hospitals & Diagnostic Centers
    • 6.3.2 Research Laboratories
    • 6.3.3 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 DNA Amplification Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global DNA Amplification market is categorized based on

By Product Type

• Polymerase Chain Reaction (PCR)
• Loop-mediated Isothermal Amplification (LAMP)
• Nucleic Acid Sequence Based Amplification (NASBA)
• Strand Displacement Amplification (SDA)
• Multiple Displacement Amplification (MDA)

By Application

• Clinical Diagnostics
• Research
• Forensics
• Others

By Distribution Channel

• Hospitals & Diagnostic Centers
• Research Laboratories
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific Inc.
• QIAGEN N.V.
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• Roche Diagnostics
• Illumina, Inc.
• NEB (New England Biolabs) Inc.
• Takara Bio Inc.
• GE Healthcare
• Promega Corporation
• Merck KGaA
• PerkinElmer, Inc.
• LGC Limited
• DiaSorin S.p.A.
• Hologic, Inc.